Clinical Trials
2 trialsNCT06736275 2026-05-15
A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors
Jiangsu Nutai Biologics Co., Ltd
Phase EARLY_PHASE1 Recruiting
NCT04906746 2025-07-28
Ruxolitinib for Cancer Cachexia
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Active not recruiting